KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 119 filers reported holding KARYOPHARM THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.17 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $255,706 | -22.6% | 190,825 | +3.4% | 0.06% | -53.6% |
| Q2 2023 | $330,468 | -95.5% | 184,619 | -52.6% | 0.12% | -74.0% |
| Q2 2020 | $7,383,000 | -18.6% | 389,807 | -17.4% | 0.48% | -39.6% |
| Q1 2020 | $9,071,000 | +44.2% | 472,182 | +43.9% | 0.80% | +54.8% |
| Q4 2019 | $6,290,000 | +61.2% | 328,118 | -19.1% | 0.52% | +92.9% |
| Q3 2019 | $3,902,000 | +55.0% | 405,617 | -3.5% | 0.27% | +62.8% |
| Q2 2019 | $2,518,000 | – | 420,372 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Delphi Management Partners VIII, L.L.C. | 2,263,006 | $35,031,000 | 23.03% |
| Palo Alto Investors LP | 5,267,652 | $81,543,000 | 4.28% |
| Fairmount Funds Management LLC | 702,351 | $10,872,000 | 3.89% |
| Birchview Capital, LP | 188,000 | $2,910,000 | 1.68% |
| Mesirow Financial Investment Management, Inc. | 22,303 | $345,250,000 | 1.09% |
| EMERALD ADVISERS, LLC | 1,822,781 | $28,217,000 | 0.94% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 1,661,236 | $25,716,000 | 0.90% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,552,504 | $24,033,000 | 0.85% |
| Altium Capital Management LP | 133,951 | $2,074,000 | 0.77% |
| Hood River Capital Management LLC | 931,754 | $14,424,000 | 0.48% |